A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke (Q36685755)
scientific article published on May 24, 2012
Language:
(P31) (Q13442814)
(P50) (Q91864225)
(P304) 46-55
(P407) (Q1860)
(P433) 1
(P478) 61
(P577) Thursday, May 24, 2012
(P921) (Q181600)
(Q107129060)
(P953) https://europepmc.org/articles/pmc3598015?pdf=render
https://europepmc.org/articles/PMC3598015
https://europepmc.org/articles/PMC3598015?pdf=render
https://doi.org/10.1016/j.annemergmed.2012.04.020
https://api.elsevier.com/content/article/PII:S0196064412004052?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0196064412004052?httpAccept=text/plain
(P1433) (Q4767847)
(P1476) "A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke" (language: en)
"A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke" (language: en)
(P2093) Greg Guzauskas
Denise M. Boudreau
Kathleen F. Villa
Susan C. Fagan
(P2860) (Q35187798)
(Q35055214)
(Q39830063)
(Q22306345)
(Q37436384)
(Q29619330)
(Q36462959)
(Q34395655)
(Q35754584)
(Q28167910)
(Q35211363)
(Q40572487)
(Q34574785)
(Q34458794)
(Q34025543)
(Q39530622)
(Q40787856)
(Q30573387)
(Q36880670)
(Q29619377)
(Q34462070)
(Q47290587)
(Q48480403)
(Q55063586)
(Q43852262)
(Q44361044)
(Q48318864)
(Q48426796)
(Q51848534)
(Q44426367)
(Q48360945)
(Q48888166)
(Q48648689)
(Q47573256)
(Q53323571)
(Q48367061)
(Q77146377)
(Q69788749)
(Q69510841)
(Q81024090)
(Q83904479)
(Q50892457)
other details
description scientific article published on May 24, 2012

External Links